Effect of repeated administration of delta 9-tetrahydrocannabinol on delayed matching-to-sample performance in rats. 1995

A Miyamoto, and T Yamamoto, and S Watanabe
Department of Pharmacology, Kyushu University, Fukuoka, Japan.

In the present study we examined the effect of repeated exposure to delta 9-tetrahydrocannabinol (THC) at a dose of 10 mg/kg (once a day for 4 days) 24 h after administration, on delayed matching-to-sample (DMTS) performance in rats using a three-lever operant apparatus. Although DMTS performance was not changed on the 1st day, it was impaired on the 2nd day. The impairment was potentiated in dependence of repeated administration. After withdrawal of THC, the impairment of DMTS performance gradually disappeared. On the 10th day after withdrawal, readministration of 10 mg/kg THC resulted in marked impairment of DMTS performance at 24 h after administration. Furthermore, a single administration of 1.0 mg/kg THC 30 min prior to the session, the dose at which a single administration did not cause impairment of DMTS performance in vehicle-treated rats, significantly decreased the number of reinforcements in the test trial. In conclusion, the present study demonstrated that repeated THC administration impaired DMTS performance under the condition of 24 h after administration, and that behavioral sensitization to this impairment developed. Furthermore, the suppressive state of lever-pressing induced by repeated THC administration may be a useful animal model for amotivational syndrome in humans.

UI MeSH Term Description Entries
D008297 Male Males
D009042 Motivation Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli. Incentives,Disincentives,Expectations,Disincentive,Expectation,Incentive,Motivations
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D012055 Reinforcement Schedule A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent. Reinforcement Schedules,Schedule, Reinforcement,Schedules, Reinforcement
D003216 Conditioning, Operant Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. Instrumental Learning,Learning, Instrumental,Operant Conditioning,Conditionings, Operant,Instrumental Learnings,Learnings, Instrumental,Operant Conditionings
D004856 Postural Balance A POSTURE in which an ideal body mass distribution is achieved. Postural balance provides the body carriage stability and conditions for normal functions in stationary position or in movement, such as sitting, standing, or walking. Postural Control,Posture Balance,Posture Control,Posture Equilibrium,Balance, Postural,Musculoskeletal Equilibrium,Postural Equilibrium,Balance, Posture,Control, Postural,Control, Posture,Equilibrium, Musculoskeletal,Equilibrium, Postural,Equilibrium, Posture,Postural Controls,Posture Balances,Posture Controls,Posture Equilibriums
D006213 Hallucinogens Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. Hallucinogen,Hallucinogenic Agent,Hallucinogenic Drug,Hallucinogenic Substance,Psychedelic,Psychedelic Agent,Psychedelic Agents,Psychotomimetic Agent,Psychotomimetic Agents,Hallucinogenic Agents,Hallucinogenic Drugs,Hallucinogenic Substances,Psychedelics,Agent, Hallucinogenic,Agent, Psychedelic,Agent, Psychotomimetic,Agents, Hallucinogenic,Agents, Psychedelic,Agents, Psychotomimetic,Drug, Hallucinogenic,Drugs, Hallucinogenic,Substance, Hallucinogenic,Substances, Hallucinogenic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013759 Dronabinol A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. THC,Tetrahydrocannabinol,delta(9)-THC,9-ene-Tetrahydrocannabinol,Marinol,Tetrahydrocannabinol, (6a-trans)-Isomer,Tetrahydrocannabinol, (6aR-cis)-Isomer,Tetrahydrocannabinol, (6aS-cis)-Isomer,Tetrahydrocannabinol, Trans-(+-)-Isomer,Tetrahydrocannabinol, Trans-Isomer,delta(1)-THC,delta(1)-Tetrahydrocannabinol,delta(9)-Tetrahydrocannabinol,9 ene Tetrahydrocannabinol,Tetrahydrocannabinol, Trans Isomer
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

A Miyamoto, and T Yamamoto, and S Watanabe
January 1980, Neuropharmacology,
A Miyamoto, and T Yamamoto, and S Watanabe
March 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
A Miyamoto, and T Yamamoto, and S Watanabe
December 1979, Pharmacology, biochemistry, and behavior,
A Miyamoto, and T Yamamoto, and S Watanabe
August 1995, European journal of pharmacology,
A Miyamoto, and T Yamamoto, and S Watanabe
March 2007, The Journal of pharmacology and experimental therapeutics,
A Miyamoto, and T Yamamoto, and S Watanabe
April 1993, Environmental research,
A Miyamoto, and T Yamamoto, and S Watanabe
May 1976, Science (New York, N.Y.),
A Miyamoto, and T Yamamoto, and S Watanabe
February 1981, The Journal of pharmacology and experimental therapeutics,
A Miyamoto, and T Yamamoto, and S Watanabe
July 1981, Journal of reproduction and fertility,
Copied contents to your clipboard!